A review of the interplay between tuberculosis and mental health

AM Doherty, J Kelly, C McDonald, AM O'Dywer… - General hospital …, 2013 - Elsevier
AIMS: Tuberculosis and mental illness share common risk factors including homelessness,
HIV positive serology, alcohol/substance abuse and migrant status leading to frequent …

Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia

GA Light, NR Swerdlow - Annals of the New York Academy of …, 2015 - Wiley Online Library
Advances in psychiatric neuroscience have transformed our understanding of impaired and
spared brain functions in psychotic illnesses. Despite substantial progress, few (if any) …

NMDA receptors in the central nervous system

KB Hansen, F Yi, RE Perszyk, FS Menniti… - … receptors: Methods and …, 2017 - Springer
NMDA-type glutamate receptors are ligand-gated ion channels that mediate a major
component of excitatory neurotransmission in the central nervous system (CNS). They are …

Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled …

T Wobrock, B Guse, J Cordes, W Wölwer, G Winterer… - Biological …, 2015 - Elsevier
Background Investigators are urgently searching for options to treat negative symptoms in
schizophrenia because these symptoms are disabling and do not respond adequately to …

D-serine as a gliotransmitter and its roles in brain development and disease

MRV Horn, M Sild, ES Ruthazer - Frontiers in cellular neuroscience, 2013 - frontiersin.org
The development of new techniques to study glial cells has revealed that they are active
participants in the development of functional neuronal circuits. Calcium imaging studies …

D-cycloserine in neuropsychiatric diseases: a systematic review

S Schade, W Paulus - International Journal of …, 2016 - academic.oup.com
D-Cycloserine, known from tuberculosis therapy, has been widely introduced to
neuropsychiatric studies, since its central active mechanism as a partial NMDA-agonist has …

Glutamatergic transmission in schizophrenia: from basic research to clinical practice

J Kantrowitz, DC Javitt - Current opinion in psychiatry, 2012 - journals.lww.com
Current Opinion in Psychiatry Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …

Improving current treatments for schizophrenia

NP Maric, MJ Jovicic, M Mihaljevic… - Drug development …, 2016 - Wiley Online Library
ABSTRACT Preclinical Research After the identification of the schizophrenia as an illness
over a century ago, treatment of affected individuals included unspecific, mostly very robust …

Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine

JT Kantrowitz, ML Epstein, O Beggel, S Rohrig… - Brain, 2016 - academic.oup.com
Schizophrenia is associated with deficits in cortical plasticity that affect sensory brain regions
and lead to impaired cognitive performance. Here we examined underlying neural …

Computational psychiatry: a Rosetta Stone linking the brain to mental illness

PR Corlett, PC Fletcher - The Lancet Psychiatry, 2014 - thelancet.com
Although psychiatry has a rich variety of models, most fail to span biological, psychological,
and social domains. Computational psychiatry offers simple, direct ways of uniting these …